Reposted by Vivek JhaVivek Jha @vjha.bsky.social · 09/04/2026Read my new editorial in the @indianjnephrol on how we fall on the hurdle of implementing high-value, guideline-directed therapies to our patients with chronic diseases t.co/Tqy7fp9N1R 031
Vivek Jha @vjha.bsky.social · 09/04/2026Read my new editorial in the @indianjnephrol on how we fall on the hurdle of implementing high-value, guideline-directed therapies to our patients with chronic diseases t.co/Tqy7fp9N1R 031
Reposted by Vivek JhaISNkidneycare @theisn.org · 17/02/2026ISN-@kdigo.org joint session: "Implementing Updated KDIGO AKI/AKD Guidelines Worldwide" 🗓️ March 29 🕤 9:25 a.m. 📍 501-502 @vjha.bsky.social #ISNWCN 111
Reposted by Vivek JhaISNkidneycare @theisn.org · 19/02/2026𝗜𝗦𝗡 𝗔𝘄𝗮𝗿𝗱𝘀: 🇮🇳 @vjha.bsky.social , winner of the 𝗝𝗲𝗮𝗻 𝗛𝗮𝗺𝗯𝘂𝗿𝗴𝗲𝗿 𝗔𝘄𝗮𝗿𝗱 🇺🇸 John Kellum, winner of the 𝗕𝘆𝘄𝗮𝘁𝗲𝗿𝘀 𝗔𝘄𝗮𝗿𝗱 🇳🇱 Ron Gansevoort, winner of the 𝗟𝗶𝗹𝗹𝗶𝗮𝗻 𝗝𝗲𝗮𝗻 𝗞𝗮𝗽𝗹𝗮𝗻 𝗣𝗿𝗶𝘇𝗲 𝗳𝗼𝗿 𝗣𝗞𝗗 #ThisIsISN #ISNAwards #ISNWCN 111
Reposted by Vivek JhaISNkidneycare @theisn.org · 03/11/2025🎙️ Check out the latest Global Kidney Care Podcast! Winston Fung leads a discussion on how climate change is shaping kidney health 🌎 with Prof. @vjha.bsky.social, Maryvonne Hourmant, @sfndt.bsky.social Past president, and Letizia De Chiara. globalkidneycarepodcast.transistor.fm/episodes/sea... 022
Reposted by Vivek JhaThe George Institute for Global Health @georgeinstitute.bsky.social · 29/08/2025Our Nutrition team took India’s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2] 121
Reposted by Vivek JhaISNkidneycare @theisn.org · 26/08/2025🏅 Prof. Vivekanand Jha @vjha.bsky.social (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY 121
Vivek Jha @vjha.bsky.social · 23/08/2025First randomization in India for EASi-KIDNEY!🎉🥳 Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support. Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH www.easikidney.orgeasikidney.orgWelcomeEASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial to assess whether in addition to standard care, the drug vicadrostat reduces the risk of kidney disease ... 081
Vivek Jha @vjha.bsky.social · 27/06/2025NOACs offer a practical solution for PMN patients at high risk of thrombosis—less monitoring, fewer clinic visits, and good safety profile, even in low-resource settings. More research needed, but early results are encouraging! #KidneyHealth #Anticoagulation 000
Vivek Jha @vjha.bsky.social · 27/06/2025New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.socialt.cohttps://indianjnephrol.org/apixaban-in-primary-membranous-nephropathy-report-from-the-itangible-registry/ 131
Vivek Jha @vjha.bsky.social · 27/06/2025Understand the journey from preclinical primate studies to human deceased donor (decedent) and living recipient transplants, and the ethical, social, regulatory, and practical implications of this technology, including its potential for scalability, cost, relevance to children. 000
Vivek Jha @vjha.bsky.social · 27/06/2025Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711t.cohttps://youtu.be/pbumiUjck1I?si=CShZCu48Gw3Ws84Z 100
Vivek Jha @vjha.bsky.social · 27/06/2025Nice case and good discussion on how to interpret clinical clues 000
Reposted by Vivek JhaArvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 25/06/2025Case Presentations in Nephrology - An Indian Society of Nephrology Initiative YouTube Recording 👉 m.youtube.com/watch?v=0yuO... Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social Presented by - Dr Jugal Mehta (Mumbai) 031
Vivek Jha @vjha.bsky.social · 24/04/2025Cholecalciferol supplementation significantly improved vascular function (flow-mediated dilation) in CKD patients, Changes in immune and vascular function were not directly linked. Findings support vitamin D’s role in immune and vascular health in CKD. 010
Vivek Jha @vjha.bsky.social · 24/04/2025Secondary analysis of RCT of High-dose cholecalciferol (vitamin D3) in non-diabetic #CKD patients. #Vit D ➡️ shifted immune balance toward anti-inflammatory TH2 cells, ➡️ ⬇️ pro-inflammatory cytokines, ⬆️ vitD-responsive gene expression ➡️ showing direct immune modulation benefits CKD. #Immunology 110
Reposted by Vivek JhaAshok @ashok81.bsky.social · 24/04/2025Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease frontiersin.org/journals/imm... @vjha.bsky.socialfrontiersin.orgFrontiers | Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease 121
Reposted by Vivek JhaInternational Society of Glomerular Disease @isgd.bsky.social · 21/03/2025Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! 🇮🇳🏖️ 011
Vivek Jha @vjha.bsky.social · 20/03/2025➡️ establishes platform for studying disease course, treatment patterns, and outcomes of GNs in India ➡️ with consent for contact regarding clinical trials and biobanking, offers recruitment potential 4 studies investigating emerging therapies ➡️ Collaboration with established international registries 000
Vivek Jha @vjha.bsky.social · 20/03/2025Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India. ➡️ The first such cohort in the developing (majority) world ➡️ Will help understand disease phenotypes in the Indian context Funded by #ICMR www.kireports.org/article/S246...kireports.orgDecoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE RegistryGlomerular diseases are a leading cause of kidney disease worldwide, especially in low-and middle-income countries. At the global level, collaborative initiatives have been started to provide informat... 130
Reposted by Vivek JhaISPD - International Society for Peritoneal Dialysis @ispd.org · 13/03/2025Happy 20th anniversary #WorldKidneyDay 🎉 Two decades of successful awareness campaigns! On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening. 0113
Vivek Jha @vjha.bsky.social · 13/03/2025Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org www.kidney-international.org/article/S008... 031
Reposted by Vivek JhaMilagros Flores @dramiliflores.bsky.social · 13/03/2025🌎Are your kidneys OK? ¿Tus riñones están bien? Vos reins vont bien? هل كليتيك بخير؟ ; आपकी किडनी ठीक है? Os seus rins estão bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social #WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky 032
Reposted by Vivek JhaShubharthi Kar @karnephro.bsky.social · 13/03/2025#WorldKidneyDay Rally in #Bangladesh. 011
Vivek Jha @vjha.bsky.social · 10/03/2025Thanks @roy-chaudhury.bsky.social and tons of colleagues from all around the world for making the Congress such a success - #WCN was really special with its theme of equity, sustainability and accountability 021
Reposted by Vivek JhaPrabir Roy-Chaudhury @roy-chaudhury.bsky.social · 17/02/2025Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting! @vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social 142
Reposted by Vivek JhaCristina Popa @nephroseeker.medsky.social · 06/02/2025@vjha.bsky.social welcoming the audience to India and #ISNWCN 041
Reposted by Vivek JhaISNkidneycare @theisn.org · 07/02/2025"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al. 🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN 122
Reposted by Vivek JhaBen Caplin @bencaplin.bsky.social · 16/01/2025First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world. If we understand where it is, maybe we can understand what it is. with @vjha.bsky.social and others 042
Vivek Jha @vjha.bsky.social · 28/01/2025The @natureportfolio.bsky.social Access to Dialysis in Low and Middle-Income Countries Commission will explore Thailand’s experiences with changing its dialysis coverage policy, offering lessons for other countries with universal health coverage systems @theisn.org @who.int @hitap.bsky.social 010
Vivek Jha @vjha.bsky.social · 28/01/2025🩺 Universal Health Coverage in Action Thailand’s PD-first policy proved dialysis can be affordable in LMICs, but its reversal raises questions about equity and sustainability. Can lessons from Thailand guide better UHC policies globally? #KidneyCare #SustainableHealthcare 110
Vivek Jha @vjha.bsky.social · 28/01/2025💡 Policy Change & Impact The abrupt dialysis policy shift in 2022 highlights the risks of untested reforms. The new commission aims to assess impacts and create evidence-based recommendations for sustainable dialysis care in LMICs. #HealthPolicy #DialysisCare 120
Vivek Jha @vjha.bsky.social · 28/01/2025🌍 Dialysis in LMICs: A Lesson from Thailand Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth 142
Reposted by Vivek JhaVivek Jha @vjha.bsky.social · 04/01/2025Good noon all, IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live. Kindly follow the link: indianjnephrol.org/current-issue/ @arvindcanchi.bsky.social @priti899.bsky.socialindianjnephrol.org2024 – A Year in Review - Indian Journal of Nephrology[article] 1136
Vivek Jha @vjha.bsky.social · 04/01/2025I draw your attention to indianjnephrol.org/breaking-bar.... The memo has not reachedindianjnephrol.orgBreaking Barriers: The Case for Inclusive Leadership in Medicine - Indian Journal of Nephrology[article] 010
Vivek Jha @vjha.bsky.social · 04/01/2025Good noon all, IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live. Kindly follow the link: indianjnephrol.org/current-issue/ @arvindcanchi.bsky.social @priti899.bsky.socialindianjnephrol.org2024 – A Year in Review - Indian Journal of Nephrology[article] 1136
Reposted by Vivek Jhakireports.bsky.social @kireports.bsky.social · 31/12/2024The Limits of Generalizability: Pitfalls of Applying Western #GFR Estimation Models to Global Populations doi.org/10.1016/j.ek... Original Article: doi.org/10.1016/j.ek... #KIRCommentary 061
Vivek Jha @vjha.bsky.social · 01/01/2025‘A letter by Richard Lambert, former editor of the Financial Times, gives a fascinating insight into how Manmohan Singh was not just about economic reforms, but reforms with a heart.’ From - The India Cable by @thewire.in 161
Reposted by Vivek JhaISNkidneycare @theisn.org · 20/12/2024📖 Don't miss our KI #ISNFridaySelection: Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients www.kidney-internati... #NephSky 0175
Reposted by Vivek JhaISNkidneycare @theisn.org · 17/12/2024Excited to see the Global Kidney Patient Trials Network (GKPTN) featured in @jama.com! Endorsed by ISN, this initiative is transforming CKD research and improving access to innovative treatments worldwide. Learn more: jamanetwork.com/jour... #Nephsky @vjha.bsky.social 043
Reposted by Vivek JhaISNkidneycare @theisn.org · 18/12/2024"Don't be shy. If you see someone who you want to ask something from, go ahead and tap them on the shoulder. Sometimes, it's these side casual conversations that end up helping people come up with great ideas." Prof. @vjha.bsky.social. 🎥 Full interview: ow.ly/FHXX50UfnoS 073
Vivek Jha @vjha.bsky.social · 06/12/2024➡️ Creatinine-based eGFR equations significantly overestimate kidney function. ➡️ Cystatin C-based equations showed less bias but still fell short of acceptable accuracy thresholds. ➡️ This underscores the need for tailored solutions for India! 🌏 #Nephrology #IndiaHealth #ClinicalResearch 120
Vivek Jha @vjha.bsky.social · 06/12/2024🧪 Did you know? ➡️ Commonly used equations to estimate kidney function (eGFR) fail to perform well in the Indian population. ➡️ Even race-neutral equations, like CKD-EPI (2021), overestimate GFR and lack accuracy. #KidneyHealth #CKD #MedicalResearch 141
Vivek Jha @vjha.bsky.social · 06/12/2024➡️ Not for the common good’—a global critique of India’s transplant system stings, but can also inspire change. ➡️ Proving them wrong starts with prioritizing equity and ethics over revenue. #HealthcareJustice #Transplantation indianjnephrol.org/transplant-p...indianjnephrol.orgTransplant Professionals and Transplant Commercialism in India: The Difficulty of Being Good - Indian Journal of Nephrology[article] 000
Vivek Jha @vjha.bsky.social · 06/12/2024"A number of transplant professionals in India could be described as ambivalent on commercialism and punitive action. Whilst there is a small number who participate in illegal acts and have even been arrested, there are many more who put forward arguments that amount to defence of their colleagues" 100
Vivek Jha @vjha.bsky.social · 06/12/2024Transplant Professionals and Transplant Commercialism in India: The Difficulty of Being Good Dr Sanjay Nagral, the co-chair of the Declaration of Istanbul Custodian Group discusses the long-lasting conundrum of transplant tourism and commercialism in India youtu.be/Z8ccIbY9ANY?...youtu.beTransplant Professionals and Transplant Commercialism in India: The Difficulty of Being GoodYouTube video by UNPACK - Indian Journal Nephrology 211
Vivek Jha @vjha.bsky.social · 05/12/2024‼️ Not intended to replace the existing guidelines ➡️ Provides over-arching structure acknowledging that access to high-quality care not available to most people worldwide ➡️ even when not delivered to the highest possible standard, this life-saving treatment helps people achieve specific life-goals 000
Vivek Jha @vjha.bsky.social · 05/12/2024A new approach to setting dialysis standards - A tiered quality framework links standards to resources, ensuring safety, efficacy, and affordability even in low-resource settings. Empowering policymakers, providers, and patients. #KidneyCare #HealthcareInnovation www.kireports.org/article/S246... 163
Reposted by Vivek JhaJay R. Seltzer, MD @jrseltzer.bsky.social · 03/12/2024Mixed cellular cast - brightfield with Prescott-Brodie stain - note how WBC's stain blue which helps to differentiate them from tubular cells - from new consult: admitted with SOB, nodular pulm infiltrate, and AKI - serologies pending. bx tomorrow ... #UrineMicroscopy #UrinarySediment 043
